EnginZyme
EnginZyme develops cell-free biomanufacturing technology that uses immobilized enzymes to make chemicals and ingredients through scalable industrial processes.
SEK 75MEquity round
ParticipantLoading investors…
Activity from announced rounds
EnginZyme develops cell-free biomanufacturing technology that uses immobilized enzymes to make chemicals and ingredients through scalable industrial processes.
HighLife Medical develops a transcatheter mitral-valve replacement system designed to treat patients with severe mitral regurgitation without open-heart surgery.
Pitching Sofinnova Partners? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room